Sox11 regulates mammary tumour-initiating and metastatic capacity in Brca1-deficient mouse mammary tumour cells

Little is known about the role of Sox11 in the regulation of mammary progenitor cells. Sox11 is expressed by mammary bud epithelial cells during embryonic mammary gland development and is not detected in mammary epithelial cells after birth. As Sox11 is an oncofetal gene, we investigated the effects...

Full description

Bibliographic Details
Main Authors: Siu Man Tsang, Hyojin Kim, Erik Oliemuller, Richard Newman, Naa-Anyima Boateng, Naomi Guppy, Beatrice A. Howard
Format: Article
Language:English
Published: The Company of Biologists 2021-05-01
Series:Disease Models & Mechanisms
Subjects:
Online Access:http://dmm.biologists.org/content/14/5/dmm046037
id doaj-f2bc5b0108d0414ea87f2f845ed7b06e
record_format Article
spelling doaj-f2bc5b0108d0414ea87f2f845ed7b06e2021-06-20T11:56:41ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112021-05-0114510.1242/dmm.046037046037Sox11 regulates mammary tumour-initiating and metastatic capacity in Brca1-deficient mouse mammary tumour cellsSiu Man Tsang0Hyojin Kim1Erik Oliemuller2Richard Newman3Naa-Anyima Boateng4Naomi Guppy5Beatrice A. Howard6 The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, SW3 6JB, UK The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, SW3 6JB, UK The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, SW3 6JB, UK The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, SW3 6JB, UK The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, SW3 6JB, UK The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, SW3 6JB, UK The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, SW3 6JB, UK Little is known about the role of Sox11 in the regulation of mammary progenitor cells. Sox11 is expressed by mammary bud epithelial cells during embryonic mammary gland development and is not detected in mammary epithelial cells after birth. As Sox11 is an oncofetal gene, we investigated the effects of reducing Sox11 levels in embryonic mammary progenitor cells and found that Sox11 regulates proliferative state, stem cell activity and lineage marker expression. We also investigated the effect of reducing Sox11 levels in two transplantable Brca1-deficient oestrogen receptor-negative mouse mammary tumour cell lines, to assess whether Sox11 regulates similar functions in tumour progenitor cells. When Sox11 levels were reduced in one Brca1-deficient mammary tumour cell line that expressed both epithelial and mesenchymal markers, similar effects on proliferation, stem cell activity and expression of lineage markers to those seen in the embryonic mammary progenitor cells were observed. Orthotopic grafting of mammary tumour cells with reduced Sox11 levels led to alterations in tumour-initiating capacity, latency, expression of lineage markers and metastatic burden. Our results support a model in which tumours expressing higher levels of Sox11 have more stem and tumour-initiating cells, and are less proliferative, whereas tumours expressing lower levels of Sox11 become more proliferative and capable of morphogenetic/metastatic growth, similar to what occurs during embryonic mammary developmental progression.http://dmm.biologists.org/content/14/5/dmm046037sox11embryonic mammary progenitor celllineagetumour-initiating cellmouse mammary tumour
collection DOAJ
language English
format Article
sources DOAJ
author Siu Man Tsang
Hyojin Kim
Erik Oliemuller
Richard Newman
Naa-Anyima Boateng
Naomi Guppy
Beatrice A. Howard
spellingShingle Siu Man Tsang
Hyojin Kim
Erik Oliemuller
Richard Newman
Naa-Anyima Boateng
Naomi Guppy
Beatrice A. Howard
Sox11 regulates mammary tumour-initiating and metastatic capacity in Brca1-deficient mouse mammary tumour cells
Disease Models & Mechanisms
sox11
embryonic mammary progenitor cell
lineage
tumour-initiating cell
mouse mammary tumour
author_facet Siu Man Tsang
Hyojin Kim
Erik Oliemuller
Richard Newman
Naa-Anyima Boateng
Naomi Guppy
Beatrice A. Howard
author_sort Siu Man Tsang
title Sox11 regulates mammary tumour-initiating and metastatic capacity in Brca1-deficient mouse mammary tumour cells
title_short Sox11 regulates mammary tumour-initiating and metastatic capacity in Brca1-deficient mouse mammary tumour cells
title_full Sox11 regulates mammary tumour-initiating and metastatic capacity in Brca1-deficient mouse mammary tumour cells
title_fullStr Sox11 regulates mammary tumour-initiating and metastatic capacity in Brca1-deficient mouse mammary tumour cells
title_full_unstemmed Sox11 regulates mammary tumour-initiating and metastatic capacity in Brca1-deficient mouse mammary tumour cells
title_sort sox11 regulates mammary tumour-initiating and metastatic capacity in brca1-deficient mouse mammary tumour cells
publisher The Company of Biologists
series Disease Models & Mechanisms
issn 1754-8403
1754-8411
publishDate 2021-05-01
description Little is known about the role of Sox11 in the regulation of mammary progenitor cells. Sox11 is expressed by mammary bud epithelial cells during embryonic mammary gland development and is not detected in mammary epithelial cells after birth. As Sox11 is an oncofetal gene, we investigated the effects of reducing Sox11 levels in embryonic mammary progenitor cells and found that Sox11 regulates proliferative state, stem cell activity and lineage marker expression. We also investigated the effect of reducing Sox11 levels in two transplantable Brca1-deficient oestrogen receptor-negative mouse mammary tumour cell lines, to assess whether Sox11 regulates similar functions in tumour progenitor cells. When Sox11 levels were reduced in one Brca1-deficient mammary tumour cell line that expressed both epithelial and mesenchymal markers, similar effects on proliferation, stem cell activity and expression of lineage markers to those seen in the embryonic mammary progenitor cells were observed. Orthotopic grafting of mammary tumour cells with reduced Sox11 levels led to alterations in tumour-initiating capacity, latency, expression of lineage markers and metastatic burden. Our results support a model in which tumours expressing higher levels of Sox11 have more stem and tumour-initiating cells, and are less proliferative, whereas tumours expressing lower levels of Sox11 become more proliferative and capable of morphogenetic/metastatic growth, similar to what occurs during embryonic mammary developmental progression.
topic sox11
embryonic mammary progenitor cell
lineage
tumour-initiating cell
mouse mammary tumour
url http://dmm.biologists.org/content/14/5/dmm046037
work_keys_str_mv AT siumantsang sox11regulatesmammarytumourinitiatingandmetastaticcapacityinbrca1deficientmousemammarytumourcells
AT hyojinkim sox11regulatesmammarytumourinitiatingandmetastaticcapacityinbrca1deficientmousemammarytumourcells
AT erikoliemuller sox11regulatesmammarytumourinitiatingandmetastaticcapacityinbrca1deficientmousemammarytumourcells
AT richardnewman sox11regulatesmammarytumourinitiatingandmetastaticcapacityinbrca1deficientmousemammarytumourcells
AT naaanyimaboateng sox11regulatesmammarytumourinitiatingandmetastaticcapacityinbrca1deficientmousemammarytumourcells
AT naomiguppy sox11regulatesmammarytumourinitiatingandmetastaticcapacityinbrca1deficientmousemammarytumourcells
AT beatriceahoward sox11regulatesmammarytumourinitiatingandmetastaticcapacityinbrca1deficientmousemammarytumourcells
_version_ 1721369682268651520